Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy

Published:2024-11 Issue: Volume:200 Page:110506
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Thomsen S.N.,Møller D.S.,Knap M.M.,Khalil A.A.,Shcytte T.,Hoffmann L.

Funder

Health Research Foundation of Central Denmark Region

Danish Cancer Research Fund

Danish Cancer Society

Publisher

Elsevier BV

Reference50 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

3. Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer;Schytte;Acta Oncol,2014

4. A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC;Hansen;Radiother Oncol,2017

5. Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy;Møller;Radiother Oncol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP